PRSS37
gene geneOn this page
Summary
PRSS37 (serine protease 37, HGNC:29211) is a protein-coding gene on chromosome 7q34, encoding Probable inactive serine protease 37 (A4D1T9). Plays a role in male fertility.
Predicted to enable serine-type endopeptidase activity. Involved in positive regulation of acrosome reaction and regulation of protein processing. Located in acrosomal vesicle.
Source: NCBI Gene 136242 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_001008270
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29211 |
| Approved symbol | PRSS37 |
| Name | serine protease 37 |
| Location | 7q34 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000165076 |
| Ensembl biotype | protein_coding |
| Entrez | 136242 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 2 nonsense_mediated_decay
ENST00000350549, ENST00000419085, ENST00000438520, ENST00000452758
RefSeq mRNA: 3 — MANE Select: NM_001008270
NM_001008270, NM_001171951, NM_001370403
CCDS: CCDS34764
Canonical transcript exons
ENST00000350549 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001152251 | 141836300 | 141836535 |
| ENSE00001206685 | 141839338 | 141839479 |
| ENSE00001393086 | 141841016 | 141841485 |
| ENSE00003496773 | 141837860 | 141838113 |
| ENSE00003502819 | 141837112 | 141837248 |
Expression profiles
Bgee: expression breadth ubiquitous, 101 present calls, max score 90.95.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0609 / max 62.2497, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86585 | 0.0609 | 3 |
Top tissues by expression
222 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 90.95 | gold quality |
| left testis | UBERON:0004533 | 90.90 | gold quality |
| testis | UBERON:0000473 | 87.82 | gold quality |
| sperm | CL:0000019 | 84.61 | gold quality |
| adult organism | UBERON:0007023 | 80.54 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.94 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 78.35 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 78.33 | gold quality |
| kidney epithelium | UBERON:0004819 | 69.54 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 65.57 | gold quality |
| myocardium | UBERON:0002349 | 63.04 | gold quality |
| endothelial cell | CL:0000115 | 56.91 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 55.87 | gold quality |
| jejunal mucosa | UBERON:0000399 | 55.74 | gold quality |
| gingival epithelium | UBERON:0001949 | 55.73 | gold quality |
| tibialis anterior | UBERON:0001385 | 55.57 | silver quality |
| pancreatic ductal cell | CL:0002079 | 55.35 | silver quality |
| quadriceps femoris | UBERON:0001377 | 55.05 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 54.92 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.80 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 54.77 | gold quality |
| vastus lateralis | UBERON:0001379 | 54.09 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| heart right ventricle | UBERON:0002080 | 52.39 | gold quality |
| right uterine tube | UBERON:0001302 | 52.07 | gold quality |
| deltoid | UBERON:0001476 | 51.83 | gold quality |
| gingiva | UBERON:0001828 | 51.22 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 50.83 | gold quality |
| cerebellar cortex | UBERON:0002129 | 50.81 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 50.75 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.93 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting PRSS37, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
| HSA-MIR-222-3P | 99.86 | 71.35 | 1337 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-4686 | 98.77 | 66.87 | 964 |
| HSA-MIR-2467-3P | 98.65 | 67.18 | 1969 |
| HSA-MIR-6873-5P | 98.45 | 66.14 | 1417 |
| HSA-MIR-5585-3P | 98.25 | 67.41 | 941 |
| HSA-MIR-1270 | 96.94 | 66.65 | 931 |
| HSA-MIR-620 | 96.94 | 66.79 | 888 |
Literature-anchored findings (GeneRIF, showing 1)
- Sperm with low PRSS37 contents exhibit abnormal activation of the proacrosin/acrosin system and premature proteolysis of ADAM2, which may impair the functional competence of human sperm in vivo (PMID:27649891)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Prss37 | ENSMUSG00000029909 |
| rattus_norvegicus | Prss37 | ENSRNOG00000012201 |
Paralogs (14): PRSS33 (ENSG00000103355), PLAT (ENSG00000104368), PLG (ENSG00000122194), PLGLB2 (ENSG00000125551), PRSS27 (ENSG00000172382), KLK15 (ENSG00000174562), PLGLB1 (ENSG00000183281), PRSS57 (ENSG00000185198), TMPRSS12 (ENSG00000186452), OVCH1 (ENSG00000187950), PRSS48 (ENSG00000189099), GZMM (ENSG00000197540), KLK9 (ENSG00000213022), PRSS50 (ENSG00000283706)
Protein
Protein identifiers
Probable inactive serine protease 37 — A4D1T9 (reviewed: A4D1T9)
Alternative names: Probable inactive trypsin-X2
All UniProt accessions (3): A4D1T9, F8WBF8, F8WDA6
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in male fertility. May have a role in sperm migration or binding to zona-intact eggs. Involved in the activation of the proacrosin/acrosin system.
Subcellular location. Cytoplasmic vesicle. Secretory vesicle. Acrosome. Secreted.
Tissue specificity. Testis-specific. Expressed in spermatids (at protein level).
Disease relevance. Patients with unexplained male infertility (UMI) show a decrease in the number of sperm cells compared to fertile men. Sperm exhibit also abnormal activation of the proacrosin/acrosin system and premature proteolysis of ADAM2.
Similarity. Belongs to the peptidase S1 family.
RefSeq proteins (3): NP_001008271, NP_001165422, NP_001357332 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001254 | Trypsin_dom | Domain |
| IPR001314 | Peptidase_S1A | Family |
| IPR009003 | Peptidase_S1_PA | Homologous_superfamily |
| IPR043504 |
Pfam: PF00089
UniProt features (7 total): disulfide bond 3, signal peptide 1, chain 1, domain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A4D1T9-F1 | 80.44 | 0.48 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 40–56, 131–198, 163–177
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 63 (showing top):
GOBP_SINGLE_FERTILIZATION, GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOCC_SECRETORY_GRANULE, GOBP_PROTEIN_MATURATION, GOBP_SPERM_EGG_RECOGNITION, GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_REGULATION_OF_PROTEIN_MATURATION, GOBP_REGULATION_OF_ACROSOME_REACTION, GOBP_ACROSOME_REACTION, GOBP_FERTILIZATION, GOBP_CELL_CELL_RECOGNITION, GOBP_REGULATION_OF_PROTEOLYSIS, GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA, GOCC_SECRETORY_VESICLE, GOBP_PROTEOLYSIS
GO Biological Process (10): proteolysis (GO:0006508), binding of sperm to zona pellucida (GO:0007339), primordial germ cell migration (GO:0008354), cell migration (GO:0016477), protein maturation (GO:0051604), regulation of protein processing (GO:0070613), positive regulation of fertilization (GO:1905516), positive regulation of acrosome reaction (GO:2000344), single fertilization (GO:0007338), positive regulation of reproductive process (GO:2000243)
GO Molecular Function (1): serine-type endopeptidase activity (GO:0004252)
GO Cellular Component (6): acrosomal vesicle (GO:0001669), obsolete extracellular space (GO:0005615), nucleus (GO:0005634), extracellular region (GO:0005576), secretory granule (GO:0030141), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 2 |
| fertilization | 2 |
| positive regulation of reproductive process | 2 |
| sperm-egg recognition | 1 |
| gamete generation | 1 |
| cell migration | 1 |
| cell motility | 1 |
| gene expression | 1 |
| protein processing | 1 |
| regulation of proteolysis | 1 |
| regulation of protein maturation | 1 |
| regulation of fertilization | 1 |
| acrosome reaction | 1 |
| regulation of acrosome reaction | 1 |
| reproductive process | 1 |
| positive regulation of biological process | 1 |
| regulation of reproductive process | 1 |
| endopeptidase activity | 1 |
| serine-type peptidase activity | 1 |
| secretory granule | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
| endomembrane system | 1 |
| secretory vesicle | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
658 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRSS37 | PRSS55 | Q6UWB4 | 686 |
| PRSS37 | PDILT | Q8N807 | 671 |
| PRSS37 | PRSS54 | Q6PEW0 | 643 |
| PRSS37 | PRADC1 | Q9BSG0 | 622 |
| PRSS37 | RNASE10 | Q5GAN6 | 615 |
| PRSS37 | ADAM2 | P78326 | 613 |
| PRSS37 | CALR3 | Q96L12 | 595 |
| PRSS37 | PMIS2 | A0A1W2PS18 | 544 |
| PRSS37 | CCDC18 | Q5T9S5 | 509 |
| PRSS37 | TEX101 | Q9BY14 | 502 |
| PRSS37 | UACA | Q9BZF9 | 502 |
| PRSS37 | SFXN4 | Q6P4A7 | 492 |
| PRSS37 | TPST2 | O60704 | 469 |
| PRSS37 | FAM170B | A6NMN3 | 456 |
| PRSS37 | ZNF490 | Q9ULM2 | 447 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRSS37 | MANBA | psi-mi:“MI:0914”(association) | 0.530 |
| GSK3A | PRSS37 | psi-mi:“MI:0914”(association) | 0.350 |
| GSK3B | PRSS37 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (22): LRP5 (Affinity Capture-MS), CD109 (Affinity Capture-MS), FUT11 (Affinity Capture-MS), MANBA (Affinity Capture-MS), LRP6 (Affinity Capture-MS), AKAP1 (Affinity Capture-MS), ARSK (Affinity Capture-MS), GPR98 (Affinity Capture-MS), PCDH20 (Affinity Capture-MS), UBR5 (Affinity Capture-MS), FAT4 (Affinity Capture-MS), PRSS37 (Affinity Capture-MS), PRSS37 (Affinity Capture-MS), GPR98 (Affinity Capture-MS), MANBA (Affinity Capture-MS)
ESM2 similar proteins: A0A1B0GVH4, A1L453, A4D1T9, A6H6T1, A8MTI9, A8QL53, A8QL57, B5U6Y3, E5RG02, O35453, O70169, P00745, P04070, P08709, P0CG03, P0DJE9, P22891, Q14BX2, Q28278, Q28661, Q2F9P2, Q2F9P4, Q2TV78, Q3V0Q7, Q402U7, Q4R7Y7, Q5FBW1, Q5M8S2, Q6AXZ6, Q6AY28, Q6IE62, Q6IE63, Q6PEW0, Q6UWB4, Q76HL1, Q7M756, Q7M761, Q7RTY5, Q7RTY7, Q7Z5A4
Diamond homologs: A4D1T9, O35205, P00760, P00761, P00762, P00763, P00764, P06868, P06871, P06872, P07146, P07477, P07478, P08426, P12788, P16049, P19799, P32821, P32822, P35030, P35031, P35032, P35033, P70059, Q29463, Q32KU2, Q32LI2, Q4R7Y7, Q5K2P8, Q5K2P9, Q5K4E3, Q5M8S2, Q6IE06, Q7JIG6, Q8BW11, Q8IYP2, Q8NHM4, Q90627, Q90628, Q90629
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
634 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:141836547:CA:C | acceptor_gain | 1.0000 |
| 7:141837132:CTT:C | donor_gain | 1.0000 |
| 7:141837133:TTT:T | donor_gain | 1.0000 |
| 7:141837134:TTC:T | donor_gain | 1.0000 |
| 7:141837135:T:A | donor_gain | 1.0000 |
| 7:141837159:T:A | donor_gain | 1.0000 |
| 7:141837172:T:A | donor_gain | 1.0000 |
| 7:141839335:A:AC | donor_gain | 1.0000 |
| 7:141839336:A:C | donor_gain | 1.0000 |
| 7:141839370:G:C | donor_gain | 1.0000 |
| 7:141836548:A:AC | acceptor_gain | 0.9900 |
| 7:141836548:A:C | acceptor_gain | 0.9900 |
| 7:141836551:C:CT | acceptor_gain | 0.9900 |
| 7:141836552:A:T | acceptor_gain | 0.9900 |
| 7:141837106:GATTA:G | donor_loss | 0.9900 |
| 7:141837107:ATTAC:A | donor_loss | 0.9900 |
| 7:141837108:TTACC:T | donor_loss | 0.9900 |
| 7:141837109:TA:T | donor_loss | 0.9900 |
| 7:141837110:ACC:A | donor_gain | 0.9900 |
| 7:141837110:ACCCC:A | donor_loss | 0.9900 |
| 7:141837111:CCC:C | donor_gain | 0.9900 |
| 7:141837859:CCA:C | donor_gain | 0.9900 |
| 7:141837972:AG:A | donor_gain | 0.9900 |
| 7:141837973:G:C | donor_gain | 0.9900 |
| 7:141837997:T:TA | donor_gain | 0.9900 |
| 7:141838112:TT:T | acceptor_gain | 0.9900 |
| 7:141841012:ATACC:A | donor_loss | 0.9900 |
| 7:141841014:A:AC | donor_gain | 0.9900 |
| 7:141841015:C:CC | donor_gain | 0.9900 |
| 7:141841015:C:T | donor_loss | 0.9900 |
AlphaMissense
1549 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:141836422:C:A | W227C | 0.997 |
| 7:141836422:C:G | W227C | 0.997 |
| 7:141837191:C:G | C163S | 0.997 |
| 7:141837192:A:T | C163S | 0.997 |
| 7:141837897:A:C | C131W | 0.997 |
| 7:141837898:C:G | C131S | 0.997 |
| 7:141837899:A:T | C131S | 0.997 |
| 7:141837149:C:G | C177S | 0.996 |
| 7:141837150:A:T | C177S | 0.996 |
| 7:141837899:A:G | C131R | 0.996 |
| 7:141839347:C:G | C56S | 0.995 |
| 7:141839348:A:T | C56S | 0.995 |
| 7:141837898:C:T | C131Y | 0.994 |
| 7:141837985:A:G | L102P | 0.994 |
| 7:141836510:C:G | C198S | 0.993 |
| 7:141836511:A:T | C198S | 0.993 |
| 7:141839346:G:C | C56W | 0.993 |
| 7:141839347:C:T | C56Y | 0.993 |
| 7:141839348:A:G | C56R | 0.993 |
| 7:141839395:C:T | C40Y | 0.993 |
| 7:141836424:A:G | W227R | 0.992 |
| 7:141836424:A:T | W227R | 0.992 |
| 7:141839394:A:C | C40W | 0.992 |
| 7:141839395:C:G | C40S | 0.992 |
| 7:141839396:A:T | C40S | 0.992 |
| 7:141837991:A:G | L100P | 0.991 |
| 7:141838093:C:A | G66V | 0.991 |
| 7:141839396:A:G | C40R | 0.991 |
| 7:141837876:C:A | W138C | 0.990 |
| 7:141837876:C:G | W138C | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000087368 (7:141837773 C>T), RS1000107818 (7:141842696 G>A), RS1000189128 (7:141843087 C>CT), RS1001376947 (7:141838611 A>G), RS1003213694 (7:141840646 T>C), RS1003455030 (7:141840012 C>A), RS1004172344 (7:141840101 T>A), RS1004631908 (7:141840341 A>G), RS1004669132 (7:141835979 G>A), RS1006133736 (7:141842821 A>G), RS1006254653 (7:141841373 T>C), RS1006648064 (7:141843238 C>G,T), RS1006706653 (7:141839971 T>G), RS1007065146 (7:141840253 T>C), RS1007132499 (7:141842469 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007880_7 | Emotional lability in attention deficit hyperactivity disorder | 8.000000e-06 |
| GCST008017_3 | Bitter taste perception (6-n-propylthiouracil) in obesity with metabolic syndrome | 8.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008475 | mood instability measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.